Ctt Pharmaceutical Holdings Stock Price Prediction
| CTTH Stock | USD 0.06 0.01 8.95% |
Oversold Vs Overbought
49
Oversold | Overbought |
Using CTT Pharmaceutical hype-based prediction, you can estimate the value of CTT Pharmaceutical Holdings from the perspective of CTT Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CTT Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying CTT because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CTT Pharmaceutical after-hype prediction price | USD 0.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CTT |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CTT Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CTT Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of CTT Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CTT Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of CTT Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CTT Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting CTT Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CTT Pharmaceutical's historical news coverage. CTT Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 24.61, respectively. We have considered CTT Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CTT Pharmaceutical is out of control at this time. Analysis and calculation of next after-hype price of CTT Pharmaceutical is based on 3 months time horizon.
CTT Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CTT Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CTT Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CTT Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.69 | 24.72 | 0.90 | 0.15 | 31 Events / Month | 7 Events / Month | In about 31 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.06 | 0.08 | 37.88 |
|
CTT Pharmaceutical Hype Timeline
CTT Pharmaceutical is currently traded for 0.06. The entity has historical hype elasticity of 0.9, and average elasticity to hype of competition of 0.15. CTT is anticipated to increase in value after the next headline, with the price projected to jump to 0.08 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is estimated to be 37.88%, whereas the daily expected return is currently at 1.69%. The volatility of related hype on CTT Pharmaceutical is about 28523.08%, with the expected price after the next announcement by competition of 0.21. CTT Pharmaceutical Holdings currently holds 87.62 K in liabilities with Debt to Equity (D/E) ratio of 0.12, which may suggest the company is not taking enough advantage from borrowing. CTT Pharmaceutical has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist CTT Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, CTT Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CTT Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CTT to invest in growth at high rates of return. When we think about CTT Pharmaceutical's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next anticipated press release will be in about 31 days. Check out CTT Pharmaceutical Basic Forecasting Models to cross-verify your projections.CTT Pharmaceutical Related Hype Analysis
Having access to credible news sources related to CTT Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict CTT Pharmaceutical's future price movements. Getting to know how CTT Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CTT Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PYPL | PayPal Holdings | 0.24 | 6 per month | 1.54 | 0.09 | 3.52 | (2.75) | 10.05 | |
| NDAQ | Nasdaq Inc | 0.37 | 10 per month | 0.74 | 0.12 | 1.86 | (1.73) | 5.20 | |
| CHH | Choice Hotels International | 0.95 | 10 per month | 0.89 | 0.11 | 2.47 | (1.86) | 7.70 | |
| MSFT | Microsoft | 4.77 | 8 per month | 1.49 | (0.05) | 2.09 | (1.85) | 8.19 | |
| VRT | Vertiv Holdings Co | (3.06) | 7 per month | 2.36 | 0.21 | 5.87 | (4.39) | 20.36 | |
| PDYN | Palladyne AI Corp | (0.14) | 9 per month | 4.07 | 0.16 | 27.15 | (8.05) | 134.13 | |
| NVDA | NVIDIA | (3.42) | 8 per month | 3.11 | 0.01 | 4.07 | (4.69) | 12.87 | |
| PGHL | Primega Group Holdings | 2.11 | 3 per month | 8.45 | 0.13 | 25.22 | (14.38) | 63.45 | |
| AXON | Axon Enterprise | (1.04) | 9 per month | 0.62 | 0.21 | 3.52 | (2.69) | 32.08 |
CTT Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine CTT price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CTT using various technical indicators. When you analyze CTT charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CTT Pharmaceutical Predictive Indicators
The successful prediction of CTT Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CTT Pharmaceutical Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CTT Pharmaceutical based on analysis of CTT Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CTT Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CTT Pharmaceutical's related companies.
Story Coverage note for CTT Pharmaceutical
The number of cover stories for CTT Pharmaceutical depends on current market conditions and CTT Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CTT Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CTT Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |